Active-ingredient Dossier

["emtricitabine"

Active-ingredient Dossier for ["emtricitabine" (nucleoside reverse transcriptase inhibitor). Australian brands, products, PBS listings, PBAC outcomes —…

Brand: ODOFORIL
Therapeutic area: Infectious Disease

What is

Emtricitabine Emtricitabine is a nucleoside reverse transcriptase inhibitor.

Australian brands containing

Emtricitabine — SYMTUZA — TRUVADA — DESCOVY — GENVOYA — ODEFSEY — STRIBILD — EVIPLERA — TENOFOVIR — TENVIR — TENOFOVIR/EMTRICITABINE

Therapeutic areas

Emtricitabine is registered in Infectious Disease, with 11 brands containing this ingredient on the ARTG.

Sponsor landscape

Five sponsors market emtricitabine in Australia: Gilead Sciences, Cipla, Janssen-Cilag, Sandoz and Alphapharm.

PBS and regulatory activity

No brands containing emtricitabine are currently PBS-listed. The latest PBAC outcome on record is from November 2019, and the latest AusPAR is from June 2016. Five brands have PBAC outcomes on record and five brands have AusPARs on record.